These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17381372)

  • 41. Clinical inquiries. Does digoxin decrease morbidity for those in sinus rhythm with heart failure?
    Fotinos C; Nashelsky J
    J Fam Pract; 2005 Jun; 54(6):556-7. PubMed ID: 15939011
    [No Abstract]   [Full Text] [Related]  

  • 42. Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?
    Fares WH
    Heart Lung; 2008; 37(3):173-8. PubMed ID: 18482628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic burden of venous thromboembolism in hospitalized patients.
    Dobesh PP
    Pharmacotherapy; 2009 Aug; 29(8):943-53. PubMed ID: 19637948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New standards, guide, programs on horizon.
    Hamill CT
    Case Manager; 2000; 11(4):30-1. PubMed ID: 11935608
    [No Abstract]   [Full Text] [Related]  

  • 45. The impact of clinical pharmacists on drug-related problems and clinical outcomes.
    Viktil KK; Blix HS
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):275-80. PubMed ID: 18248511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occupational medicine practice guidelines.
    Bruckman RZ; Harris JS
    Occup Med; 1998; 13(4):679-91. PubMed ID: 9928508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prescribing medications for geriatric patients in the managed care setting.
    Golden AG; Silverman MA; Preston RA
    Am J Manag Care; 2000 May; 6(5):610-8; quiz 619-21. PubMed ID: 10977468
    [No Abstract]   [Full Text] [Related]  

  • 48. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence-based medicine and practice guidelines: application to genetics.
    Toriello HV; Goldenberg P
    Am J Med Genet C Semin Med Genet; 2009 Aug; 151C(3):235-40. PubMed ID: 19621463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac rehabilitation coordinators' perceptions of patient-related barriers to implementing cardiac evidence-based guidelines.
    Fernandez RS; Davidson P; Griffiths R
    J Cardiovasc Nurs; 2008; 23(5):449-57. PubMed ID: 18728518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are the heart failure guidelines being implemented in primary care?
    Moscavitch SD; Garcia JL; Rosa LF; Pestana PR; Moraes LV; da Silva CO; Moutinho MA; Coelho FA; Rosa ML; Mesquita ET
    Rev Port Cardiol; 2009 Jun; 28(6):683-96. PubMed ID: 19697796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden.
    Kolansky DM
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S36-41. PubMed ID: 19355807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
    Mason CM
    J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Manoguerra AS; Erdman AR; Woolf AD; Chyka PA; Caravati EM; Scharman EJ; Booze LL; Christianson G; Nelson LS; Cobaugh DJ; Troutman WG;
    Clin Toxicol (Phila); 2008 Aug; 46(7):661-76. PubMed ID: 18608263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of evidence-based studies in the application of GAPS.
    Strasburger VC
    Am Fam Physician; 1998 Nov; 58(7):1550, 1552. PubMed ID: 9824955
    [No Abstract]   [Full Text] [Related]  

  • 57. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
    Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
    J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.